Home › NDC Lookup › RxCUI directory › RxCUI 578018

Bromfenac 0.9 MG/ML Ophthalmic Solution — RxCUI 578018

RxNorm drug concept · Semantic clinical drug
RxCUI 578018 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI578018
Official nameBromfenac 0.9 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbromfenac 0.09 % Ophthalmic Solution; bromfenac 0.9 MG/ML (bromfenac sodium 1.035 MG/ML) Ophthalmic Solution
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)836 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bromfenac Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats inflammation and reduces eye pain after cataract surgery. It's an NSAID, the same general drug class as ibuprofen, but made as an eye drop.
  • It is generally used once a day in the operated eye, starting the day before surgery. You continue on the day of surgery and through the first 14 days afterward. Follow your surgeo...
  • Take out contact lenses before putting the drops in, and wait at least 10 minutes before putting them back. Other eye drops are fine to use with it, but space them at least 5 minut...
  • Can I wear my contacts or use other drops?
📖 Read our full Bromfenac Ophthalmic guide →

🕸️ Concept Web — How Bromfenac 0.9 MG/ML Ophthalmic Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bromfenac 0.9 MG/ML Ophthalmic Solution RxCUI 578018

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bromfenac 19737
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bromfenac Ophthalmic Solution 578017
    • Bromfenac Ophthalmic Product 1163102
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Bromfenac 0.9 MG/ML 578016

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bromfenac 0.9 MG/ML SCDC · 578016
  • Bromfenac Ophthalmic Solution SCDF · 578017
  • Bromfenac Ophthalmic Product SCDG · 1163102

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 578018 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
46708-0508-17 1 BOTTLE in 1 CARTON (46708-508-17) / 1.7 mL in 1 BOTTLE bromfenac Alembic Pharmaceuticals Limited 2022-11-10
62332-0508-17 1 BOTTLE in 1 CARTON (62332-508-17) / 1.7 mL in 1 BOTTLE Bromfenac Ophthalmic Solution 0.09% Alembic Pharmaceuticals Inc. 2019-06-21
65862-0789-17 1 BOTTLE in 1 CARTON (65862-789-17) / 1.7 mL in 1 BOTTLE Bromfenac Aurobindo Pharma Limited 2022-03-18
68083-0313-01 1 BOTTLE, DROPPER in 1 CARTON (68083-313-01) / 1.7 mL in 1... BROMFENAC Gland Pharma Limited 2020-03-17
68180-0436-01 1 BOTTLE in 1 CARTON (68180-436-01) / 1.7 mL in 1 BOTTLE Bromfenac Lupin Pharmaceuticals, Inc. 2024-02-02
72266-0142-01 1 BOTTLE, DROPPER in 1 CARTON (72266-142-01) / 1.7 mL in 1... BROMFENAC Fosun Pharma USA Inc. 2020-07-06
72485-0649-71 1 BOTTLE, DROPPER in 1 CARTON (72485-649-71) / 1.7 mL in 1... Bromfenac ARMAS PHARMACEUTICALS INC. 2023-10-26
73614-0732-03 1 KIT in 1 CARTON (73614-732-03) * 5 mL in 1 BOTTLE, PLAST... STRENZA PLUS Brisk Pharmaceuticals 2025-02-10
Observed labelers: Alembic Pharmaceuticals Inc. (1) · Alembic Pharmaceuticals Limited (1) · ARMAS PHARMACEUTICALS INC. (1) · Aurobindo Pharma Limited (1) · Brisk Pharmaceuticals (1) · Fosun Pharma USA Inc. (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.